Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection.
Young Dal LeeSung Eun KimSeun Ja ParkMoo In ParkWon MoonJae Hyun KimKyoungwon JungJiyun SongPublished in: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2021)
The eradication rate of the 7-HEAC group was higher than that of the 7-NEAC group. Nevertheless, more effective first-line therapies may be necessary for H. pylori eradication in the near future.